Novel cardiovascular risk factors: Do they add value to your practice?

American Family Physician

Volumn 67, Issue 2, 2003, Pages

  Mosca, Lori ^a,b  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FOLIC ACID; HOMOCYSTEINE; LIPOPROTEIN A; PYRIDOXINE;

AMINO ACID BLOOD LEVEL; ATHEROSCLEROSIS; BLOOD PRESSURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; EDITORIAL; FRUIT; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; OBESITY; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; RISK FACTOR; VEGETABLE; VITAMIN SUPPLEMENTATION;

C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; HOMOCYSTEINE; HUMANS; RISK FACTORS;

EID: 0037437901     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (9)

1. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97.
2. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
3. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-8.
4. Mosca L. C-reactive protein - to screen or not to screen. N Engl J Med 2002;347:1615-7.
5. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
6. Vermeulen EG, Stehouwer CD, Twisk JW, van den Berg M, de Jong SC, Mackaay AJ, et al. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 2000;355:517-22.
7. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
8. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;330:132-7.
9. Craig WY, Neveux LM, Palomaki GE, Cleveland MM, Haddow JE. Lipoprotein(a) as a risk factor for ischemic heart disease: meta-analysis of prospective studies. Clin Chem 1998;44:2301-6.